Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity. | Vaccines (Basel) | 2023 | 36992252 | PubTator, text mining | PubMed |
| Assessment of GO-Based Protein Interaction Affinities in the Large-Scale Human-Coronavirus Family Interactome. | Vaccines (Basel) | 2023 | 36992133 | PubTator, text mining | PubMed |
| A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity. | Molecules | 2023 | 36985705 | PubTator, text mining | PubMed |
| Crosstalk between Autophagy and RLR Signaling. | Cells | 2023 | 36980296 | PubTator, text mining | PubMed |
| Caveolae Mechanotransduction at the Interface between Cytoskeleton and Extracellular Matrix. | Cells | 2023 | 36980283 | PubTator, text mining | PubMed |
| Potential Treatment Options for Neuroblastoma with Polyphenols through Anti-Proliferative and Apoptotic Mechanisms. | Biomolecules | 2023 | 36979499 | PubTator, text mining | PubMed |
| Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2. | Nat Commun | 2023 | 36977673 | PubTator, text mining | PubMed |
| Porcine Epidemic Diarrhea Virus nsp7 Inhibits MDA5 Dephosphorylation to Antagonize Type I Interferon Production. | Microbiol Spectr | 2023 | 36975829 | PubTator, text mining | PubMed |
| IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity. | NPJ Precis Oncol | 2023 | 36966223 | PubTator, text mining | PubMed |
| Integrative proteogenomic characterization of early esophageal cancer. | Nat Commun | 2023 | 36966136 | PubTator, text mining | PubMed |
| Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9. | Stem Cell Res | 2023 | 36965407 | PubTator, text mining | PubMed |
| Pharmacotherapeutic Potential of Natural Products to Target the SARS-CoV-2 PLpro Using Molecular Screening and Simulation Approaches. | Appl Biochem Biotechnol | 2023 | 36961512 | PubTator, text mining | PubMed |
| HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylation. | Elife | 2023 | 36961408 | PubTator, text mining | PubMed |
| Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer. | Noncoding RNA | 2023 | 36960964 | PubTator, text mining | PubMed |
| Modeling structure-activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics. | Front Endocrinol (Lausanne) | 2023 | 36950681 | PubTator, text mining | PubMed |
| Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses. | EMBO Mol Med | 2023 | 36946379 | PubTator, text mining | PubMed |
| Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks. | Virology | 2023 | 36940641 | PubTator, text mining | PubMed |
| In-silico studies of Momordica charantia extracts as potential candidates against SARS-CoV-2 targeting human main protease enzyme (Mpro). | Inform Med Unlocked | 2023 | 36935867 | PubTator, text mining | PubMed |
| A central chaperone-like role for 14-3-3 proteins in human cells. | Mol Cell | 2023 | 36931259 | PubTator, text mining | PubMed |
| A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants. | Signal Transduct Target Ther | 2023 | 36928316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=18